Abstracts - faqs.org

Abstracts

Law

Search abstracts:
Abstracts » Law

A McVeigh acquittal? Prosecutors face major evidentiary hurdles when trial starts Mar. 31

Article Abstract:

Rumor has it that the prosecutors of accused Oklahoma City bomber Timothy McVeigh confront major hurdles when the trial starts Mar. 31, 1997. The 2 pretrial years have revealed significant problems with the prosecution's case. These include the credibility problems of eyewitnesses, the lack of evidence on the most important charge, the detonation of the bomb, the problems with the state's forensic evidence due to controvery about the FBI crime laboratory and the importance in the case of the mystery conspirator but the lack of positive identification of this person. Convicting McVeigh of conspiracy will be easier than convicting him of the actual bombing. This is another criminal case built mainly on circumstantial evidence.

Author: Ross, Ryan
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 1997
United States, Conspiracy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Withdrawal move difficult for Oklahoma City lawyer; he says he's 'a defense lawyer down to (his) toenails' but must beg off

Article Abstract:

Oklahoma City lawyer John W. Coyle and public defender Susan Otto have both sought to withdraw as defense counsel for accused bomber Timothy McVeigh. US Magistrate Ronald L. Howland denied those requests on Apr 26, 1995, but a short list of other possible defense lawyers is rumored to exist. Coyle says that despite the case's appeal to him as a defense lawyer, he lost friends in the explosion and might be unable to provide objective counsel. Other lawyers said to be interested in the case include Gerry Spence and Kevin McNally.

Author: Blum, Andrew
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 1995
Beliefs, opinions and attitudes, Public defenders, Oklahoma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subway bomber defense tries risky route: they say drug combination made him insane. But experts say that defense is a long shot

Article Abstract:

Edward Leary's defense team will gamble on a rarely successful plea of insanity due to a combination of antidepressant drugs in his trial for the firebombing of a New York City, NY subway car. Sole practitioners Ira D London and Robert Fogelnest claim Prozac, Buspar, Effexor, and Wellbutrin, given by a doctor who provided no other care, forced the already depressed Leary into a state of insanity. While admitting his role in the bombing, they contend he had no harmful intent. The high-profile trial will have no TV cameras.

Author: Blum, Andrew
Publisher: ALM Media, Inc.
Publication Name: The National Law Journal
Subject: Law
ISSN: 0162-7325
Year: 1996
Antidepressants, Insanity defense, New York (State), Leary, Edward

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Cases, Oklahoma City Bombing, 1995, Bombings, McVeigh, Timothy
Similar abstracts:
  • Abstracts: Suite harmony; protecting client confidentiality while you share space. Bad references: beware of ethical hazards when nonlawyers offer referral fees
  • Abstracts: Professors charge that bar exam in Louisiana is racially biased. Transition lawyers scrutinized; law professors prominent, but some say they lack exposure to business world
  • Abstracts: Circuit prohibits import of gray market goods; the 9th Circuit rules first sale doctrine can't limit import ban
  • Abstracts: Mutual funds may face problems unless they defer all post-October capital losses. Mutual funds can use stock redemptions to meet distribution requirements
  • Abstracts: Provisional and protective measures under Austrian Arbitration Law. 'First experiences' with the new Austrian Arbitration Law: a German perspective
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.